While it was an amusing name, the idea to be leveraged 300% short healthcare stock was not the best idea, which is why that SICK ETF is now discontinued. Its benign twin, an ETF that leveraged 300% long healthcare sector stock is however still in operation with a name almost as funny, the CURE ETF.
Information provided on stocksgorilla.com is not intended to be financial advice. Stocksgorilla do not receive compensation for writing about the companies in question. To avoid conflicts of interest, Stocksgorilla’s writers have no holdings in the listed companies we write about. Articles about companies shall not be construed as a recommendation or solicitation to invest in the companies described. Stocksgorilla cannot guarantee that any statements presented in the articles will be met. Stocksgorilla cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information om this website. Users of this website are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision. For complete terms see: stocksgorilla.com/terms.
The Rivian R1T travels almost everywhere – it has four
Apple has shown an almost uncanny development even without Steve
This isn’t the first time the Tesla CEO has squared
Purdue Pharma’s OxyContin. Photo: George Frey The pharmaceutical company Purdue
